Evidence map›Paper›PMID 29568754›Full record

ArticleBioMed research international2018

Monoamine Oxidase-A Inhibition and Associated Antioxidant Activity in Plant Extracts with Potential Antidepressant Actions.

Tomás Herraiz, Hugo Guillén

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
7.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 80 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Nutrients · 2024
    Article
  9. Documentary Analysis ofPharmaceuticals (Basel, Switzerland) · 2024
    Review
  10. Chemical Composition and Biological Activity ofPlants (Basel, Switzerland) · 2024
    Article
  11. Article
  12. Article
  13. Biological Activity of Genus Hypericum Sect.Molecules (Basel, Switzerland) · 2023
    Article
  14. A Novel Aniline Derivative fromInternational journal of molecular sciences · 2023
    Article
  15. Pharmaceuticals (Basel, Switzerland) · 2023
    Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Tomás HerraizInstituto de Ciencia y Tecnología de Alimentos y Nutrición (ICTAN), Spanish National Research Council (CSIC), Juan de la Cierva 3, 28006 Madrid, Spain.ORCID 0000-0003-3682-9227
Hugo GuillénInstituto de Ciencia y Tecnología de Alimentos y Nutrición (ICTAN), Spanish National Research Council (CSIC), Juan de la Cierva 3, 28006 Madrid, Spain.
Consejo Superior de Investigaciones Científicas · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Monoamine oxidase (MAO) catalyzes the oxidative deamination of amines and neurotransmitters and is involved in mood disorders, depression, oxidative stress, and adverse pharmacological reactions. This work studies the inhibition of human MAO-A by

Indexed as

AlkaloidsAnthracenesAntidepressive AgentsAntioxidantsFlavonoidsHumansHypericumLepidiumMonoamine OxidaseMonoamine Oxidase InhibitorsPeganumPerylenePhloroglucinolPlant ExtractsTerpenesTriterpenesadhyperforinAlkaloidsAnthracenesAntidepressive AgentsAntioxidantsFlavonoidshyperfoliatinhyperforinhypericinMonoamine Oxidasemonoamine oxidase A, humanMonoamine Oxidase InhibitorsPerylenePhloroglucinolPlant ExtractspseudohypericinTerpenesTriterpenes

Identifiers

PMID29568754
PMCPMC5820675
OpenAlexW2782962658

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.